Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONFIRM: Olmesartan for Carotid Atherosclerosis
NCT01132768Phase 4Terminated
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan in hypertension (HTN), carotid atheroma (CAS), sponsored by Daiichi Sankyo Co., Ltd.. Started May 2010; status: terminated.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT01132768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01132768.